iBio Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Share-Based Compensation - Stock Options and Warrants (Detail) - Schedule of stock-based compensation expense

Share-Based Compensation - Stock Options and Warrants (Detail) - Schedule of stock-based compensation expense (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Allocated Share-based Compensation Expense	$ 338,799	$ 611,948	$ 1,009,198	$ 2,006,052
Research and Development Expense [Member]
Allocated Share-based Compensation Expense	74,661	58,475	177,874	81,662
General and Administrative Expense [Member]
Allocated Share-based Compensation Expense	$ 264,138	$ 553,473	$ 831,324	$ 1,924,390

- Definition

Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.

+ References + Details